Pfizer, illegal exploitation

£70 million in fines for pharma firms Overcharged NHS Phenytoin sodium Important anti-epilepsy medicine Pfizer fined £63 million Flynn fined 6.7 million NHS costs for rose from 2 million to 50 million in a single year CMA CEO: “These firms illegally exploited their dominant positions to charge the NHS excessive prices and make more money for themselves – meaning patients and taxpayers lost out” Fines are the result of an in-depth investigation Competition and Markets Authority Pfizer and Flynn charged unfairly high prices for capsules, for over 4 years, ultimately paid for by the NHS. Firms de-branded the drug, previously known as Epanutin, meaning it was no longer subject to price regulation and the firms could set prices at their discretion. Pfizer and Flynn were the dominant supplier